Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy: A dual approach for triple-negative breast cancer treatment

Authors:

Abstract
No abstract available
Funding Information
  • Universiteit Gent (2021.01773)
  • Carlos III Health Institute (PI22/01253)
  • Foundation for Science and Technology (POCI-01-0145-FEDER-31859/2017, PTDC/MED-ONC/4165/2021, DL 57/2016/CP1360/CT0009)
  • European Regional Development Fund
  • Ministerio de Ciencia, Innovación y Universidades
  • Chartered Institute of Management Accountants
  • Universidad de Navarra (CEECIND/00697/2018, RYC2022-038084-I)
  • European Commission (2021.01773, PI22/01253)
  • European Cooperation in Science and Technology (CA21135)

This publication has 53 references indexed in Scilit: